14th CEE Meeting on Viral Hepatitis and HIV

Program

Thursday, 11 October9:00 Opening of the meeting

Session 1 Epidemiology of HIV and hepatitis in the CEE countries

9:10 Epidemiology of HIV Infection and Treatment in EuropeTeymur Noori, MScEuropean Centre for Disease Prevention and Control (ECDC), Solna, Sweden

9:35 Update on changes in Hepatitis B and C in CEE countriesMiłosz Parczewski, MD, PhD Pomeranian Medical University, Szczecin, Poland

10:00 How can new diagnostics help to increase the number diagnosed?Francesco Marinucci, PhDFIND, Geneva, Switzerland

10:25 Roundtable discussion

11:10 Coffee break

Session 2 Challenges in HIV and viral hepatitis

11:40 Hepatitis Delta: what are the new developments, what are the challenges?Cihan Yurdaydin, MD, PhDAnkara University Medical Centre, Ankara, Turkey

12:05 HIV & women’s health: do we have any game changers here?Speaker to be confirmed

12:30 Discussion

12:45 Group picture and lunch

Special session: Improving care of treatment-experienced patients

13:45 Approach to managing treatment-experienced patients Jonathan Schapiro, MDSheba Medical Centre, National Hemophilia Centre, Tel Aviv, Israel

14:00 Utilizing new diagnostics, web-tools and drugs for optimal care of treatment-experienced patients. A case-based joint presentationSpeakers to be confirmed

14:15 Treatment-experienced patients in Central and Eastern Europe – What needs to be done? Speaker to be confirmed

14:30 Discussion

24th CEE Meeting on Viral Hepatitis and HIV

Session 3 Switching HIV therapy: considerations and strategies

14:45 Clinical considerations in switching antiretroviral therapyDavid Jilich, MDHIV Centre Prague, Prague, Czech Republic

15:05 Clinical Case Discussion: Switching HIV TherapyPavel Khaykin, MDMainFachArtzt, Frankfurt Am Main, Germany

15:25 Discussion

15:35 Coffee break

Session 4 Abstract - driven presentations

16.05Real-life effectiveness of ledipasvir/sofosbuvir regimen and factors associated with retention in care among HIV/HCV co-infected PWID in Ukraine

Tetyana Kyrychenko, Ukraine

#1

16.15 Possible misclassification of HIV transmission between men: results of phylogenetic analysis

Natia Dvali, Georgia

#2

16.25 Epidemiology of HIV in the Baltic countries (Estonia, Latvia, Lithuania)

Saulius Caplinskas, Lithuania

#3

16:35 Approaches to providing hepatitis C viremia testing to people who inject drugs in Georgia

Maia Japaridze, Georgia

#4

16:45 Spontaneous HCV clearance in HCV/HIV coinfected patients from AIDS Center Prague

Viktor Aster, Czech Republic

#5

15:05 Discussion

17:00 Industry - sponsored symposium

18:00 Welcome reception and poster viewing

19:30 Group dinner (pre-registration required)

Program

34th CEE Meeting on Viral Hepatitis and HIV

XxxxxxProgram

Friday, 12 October8:30 Industry - sponsored symposium

Session 5 Management of hepatitis C

9:30 Critical assessment of the global epidemiology of HCVPeter Ferenci, MD University of Vienna, Vienna, Austria

9:55 Liver transplantation for HCV and HBV in The Czech RepublicSoña Frankova, MD, PhDIKEM Prague transplant center, Prague, Czech Republic

10:20 Case Study: The changing IV drug use problem/pattern and what that means to the epidemicMojca Maticic, MD, PhDUniversity Medical Centre Ljubljana, Ljubljana, Slovenia

10:45 The EpiTer-2 databaseRobert Flisiak, MD, PhDMedical University of Bialystok, Bialystok, Poland

11:05 Discussion

11:15 Coffee break

Session 6 Hepatitis B cure strategies: how far are we?

11:45 Hepatitis B cure strategies: how far are we? Heiner Wedemeyer, MDUniversity Clinic Essen, Essen, Germany

Abstract-driven presentations12:10 Mortality and causes of death among HIV/HCV co-infected persons in

the Eastern European country of GeorgiaAkaki Abutidze,

Georgia #6

12:20 HCV resistance-associated variants among HCV treatment naïve HIV-coinfected patients in Ukraine. A pilot study

Marta Vasylyev, Ukraine #7

12:30 Lunch

Session 7 Hot topics in HIV and hepatitis

13:30 New delivery systems and long acting antiretroviral drugsDavid Back, PhDUniversity of Liverpool, Liverpool, United Kingdom

13:55 HIV PrEPPep Coll, MDHospital Universitari Germans Trias i Pujol, Badalona, Spain

44th CEE Meeting on Viral Hepatitis and HIV

Xxxxxx

Abstract-driven presentations

14:20 Early results of pre-exposure prophylaxis program in GeorgiaNikoloz

Chkhartishvili, Georgia

#8

14:30 The Regression of Liver Fibrosis in HCV Cirrhotic Patients WhoRegistered SVR after DAA TherapyAnca Leustean,

Romania #9

14:40 Socio-demographic risk factors for high HEV seroprevalence amongliver transplant recipients in CroatiaAnna Mrzljak,

Croatia #10

14:50 Insulin-like growth factor and platelet-derived growth factor in livercells of patients with chronic hepatitis C at different stages of fibrosisIgor Tikhonov,

Russia #11

15:00 Closing remarks

Program